5 Companies That Destroyed Shareholders Last Week
Sarepta Therapeutics and Globalstar are among the companies that punished shareholder the most this past week.
All Work
Chris Lange
The 3 Most Important Earnings of the Coming Week
24/7 Wall St. has put together a preview of Lululemon Athletica and a few other major companies reporting their quarterly results this week.
SEC Freezes Assets of Husband and Wife in Cancer Treatment Scam
The SEC has announced fraud charges and an asset freeze against a husband and wife accused of misusing money they raised from investors for the purpose of building and operating a new cancer treatment…
SEC Charges Advisor With Defrauding Investors
The U.S. Securities and Exchange Commission (SEC) charged a North Carolina-based investment adviser with defrauding investors.
5 Stocks on the Move After Employment Report
After a weaker than expected Employment Situation report, the broad markets took a downturn across the board in Friday’s trading session.
Why Ambarella Earnings Are Finally Decoupled From GoPro
Ambarella reported better-than-expected fiscal first-quarter financial results after markets closed on Thursday.
6 Biotechs Seriously on the Move
A few biotech companies made fantastic runs in Thursday’s session. We have included information about each company, as well as recent trading activity and the consensus price target.
What to Expect From Ambarella Earnings
Ambarella is scheduled to report its fiscal first-quarter financial results after the markets close on Thursday.
Is Johnson & Johnson Overpaying for Vogue?
Johnson & Johnson has entered into a definitive agreement to acquire Vogue, a privately held hair products company, for $3.3 billion in cash.
NantHealth Explodes Into the Market With IPO
Nant Health entered the market with a bang on Thursday. Despite pricing at $14 per share, the stock opened at $16.11 and went higher.
SEC Charges Wall Street Brokerage Firm With Anti-Money Laundering Failures
The SEC has charged a Wall Street-based brokerage firm with failing to sufficiently evaluate or monitor customers’ trading for suspicious activity as required under the federal securities laws.
Merrill Lynch Picks ASCO Winners
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it is looking…
SEC Settles Charges With Equity Fund Adviser for Acting as Unregistered Broker
The SEC has announced that a Maryland-based private equity fund advisory firm and its owner have agreed to pay more than $3 million to settle charges.
Why Conn’s Earnings Were Not Up to Snuff
Conn's reported disappointing fiscal first-quarter financial results before the markets opened on Thursday.
Jeld-Wen Files for IPO
Jeld-Wen Holding has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Clearside Biomedical Changes Up Pricing for IPO
Clearside Biomedical expects to price more than 7 million shares at $7 per share for an initial public offering valued up to nearly $58 million.
SEC Charges California Firm With Ponzi Scheme
The U.S. Securities and Exchange Commission (SEC) has recently charged two California men and their investment firm with operating a Ponzi scheme. They claimed to specialize in serving middle-class investors and securing exorbitant returns…
Why Credit Suisse Says to Buy Whole Foods Now
Credit Suisse has upgraded Whole Foods to an Outperform rating from Neutral and raising its price target to $40 from $30.
Is Salesforce Overpaying for Demandware?
Demandware shares skyrocketed on Wednesday following the announcement of its agreement to be acquired by Salesforce.com.
SEC Charges Nashville Firm in Scheme to Collect Extra Fees
The SEC has charged a Nashville-based investment advisory firm and its owner with scheming to collect extra monthly fees from a pair of hedge funds they managed.